Thymopentin (TP 5) in the management of patients with uremia.
Bonaccorso
R
R
Chair of Hematology, Institute of Clinical Medicine, Institute of Clinical Medicine, University of Palermo, Italy.
Gebbia
V
V
Tambone Reyes
M
M
Pappalardo
M S
MS
Peralta
S
S
La Iuppa
M
M
Teresi
M
M
Di Marco
P
P
Citarrella
P
P
Mansueto
S
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D007958:Leukocyte Count; D012016:Reference Values; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D016305:Thymopentin / Q000627:therapeutic use*; D014511:Uremia / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D016305:Thymopentin